This website uses cookies, pixel tags, and similar technologies (âCookiesâ) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking âAccept Allâ you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link âCookie Preferencesâ in the footer of our website.
Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.
Bausch Health is in talks with third parties on potential new financing, according to 9fin sources.
The move comes as existing creditors are locked in a massive cooperation agreement, which is in effect until October of 2025. Bausch is also staring down at a more than $20bn debt pile, with nearly $2.4bn coming due in 2025.
We're trusted by the top 10 Investment Banks
Asset management firms with a combined total of over $17trn AUM
80% of trading desks by estimated European high yield volume
High yield franchises at leading US and European law firms
